Biotechnology - 2d Quarter, 1999
| Name |
City |
State |
Amount |
Financing |
Description |
Investors |
| MicroCHIPS |
Cambridge |
MA |
$250,000 |
First |
Drug delivery technology. |
Polaris Venture Partners |
| Mnemoscience Corporation |
Newton |
MA |
$97,000 |
Bridge |
Shape memory biomaterials to create physician-controlled medical devices and drug delivery systems. |
Polaris Venture Partners |
| NitroMed Inc. |
Bedford |
MA |
$11,000,000 |
Fourth & Beyond |
Develops new medicines utilising nitric oxide. |
Atlas Venture, Boston University Community Technology Fund, HealthCare Ventures, Johnson & Johnson Development Corp., Lombard Odier Immunology Fund, Rho Management, Senmed Medical Ventures |
| t. Breeders Inc. |
Worcester |
MA |
$5,500,000 |
Mezzanine |
Proprietary technology designed to selectively amplify (breed) a clonogenic pool of relatively undifferentiated cells. |
BB Bioventures L.P., Tullis-Dickerson & Co. Inc. (The Javelin Fund) |
| Therion Biologics Corporation |
Cambridge |
MA |
$10,500,000 |
Fourth & Beyond |
Cancer and AIDS immunotherapeutic vaccines. |
BioVentures Investors, Hambrecht & Quist Venture Capital, Loeb Partners Corp., Northwood Ventures, Pacific Horizon Partners II, S.R. One Ltd., Sofinnova Ventures Inc. |
| |
|
|
$27,347,000 |
|
|
0 |
|
Venture capital recipients in New England, by industry, canvassed as part of
the second-quarter 1999 Boston Globe/PricewaterhouseCoopers Money Tree Survey
|
|
|
